Skip to main content
Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes.
Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer.
As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

More about this publication?
Volume 7, Number 7, 2007

Articles

Pathobiology of Head and Neck Squamous Tumorigenesis
pp. 606-612(7)
Author: El-Naggar, Adel K.

Favourites:
ADD
Favourites:
ADD

Current Status and Future Perspectives of Chemoprevention in Head and Neck Cancer
pp. 623-632(10)
Authors: Klass, Carmen M.; Shin, Dong M.

Favourites:
ADD
Favourites:
ADD

Targeting Angiogenesis in Head and Neck Cancer
pp. 643-649(7)
Authors: Saba, Nabil F.; Shin, Dong M.; Khuri, Fadlo R.

Favourites:
ADD

EGFR-Targeting Monoclonal Antibodies in Head and Neck Cancer
pp. 650-665(16)
Authors: Astsaturov, Igor; Cohen, Roger B.; Harari, Paul

Favourites:
ADD

Recent Advances in Combined Modality Therapy for Locally Advanced Head and Neck Cancer
pp. 674-680(7)
Authors: Wirth, Lori J.; Posner, Marshall R.

Favourites:
ADD

Recent Approaches in Chemoprevention of Prostate Cancer
pp. 681-688(8)
Author: Young, Charles Y.F.

Favourites:
ADD

Targeting MDM2 and MDMX in Retinoblastoma
pp. 689-695(7)
Authors: Laurie, Nikia A.; chin-Shih, Chie; Dyer, Michael A.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content